Skip to content

PROGAV 2.0 FX674TRecalls & reported problems

Aesculap AG · PROGAV 2.0 W/SA2.0 25 & PED.CONTROL RES. · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04041906502287), received between Aug 6, 2021 and Aug 6, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1

Patient problems

  • Hydrocephalus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 6, 2021Infusion or Flow Problem; Infusion or Flow Problem

    IT WAS REPORTED THAT A PROGAV 2.0 (#FX674T) WAS IMPLANTED DURING A PROCEDURE PERFORMED ON (B)(6) 2020. ACCORDING TO THE COMPLAINANT, THE VALVE WAS BELIEVED TO HAVE A BLOCKAGE. THE PATIENT UNDERWENT A REVISION PROCEDURE. THE COMPLAINANT DEVICE WAS RETURNED TO THE MANUFACTURER FOR EVALUATION. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE REVISION PROCEDURE. AGE: (B)(6) YEARS, HEIGHT: 184 CM, WEIGHT: (B)(6) KG, GENDER: UNKNOWN. THE SAME EVENT: MEDWATCH#3004721439-2021-00218.

    Patient problems: Hydrocephalus

    MAUDE report 12289245 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page